KRTAP1-3 and cancer: This is particularly important as genetic manipulation of hiPSC, such as the stepwise introduction of an oncogenic signal in PSCs derived from healthy donors, is considered a promising way to develop synthetic cancer stem cells that may serve as a drug screening pipeline for B2B or B2C businesses.